Lilly Ventures is a private equity general partner firm headquartered in South Indianapolis, IN, United States.
VA-based clinical stage biotechnology firm Cavion has raised $26.1m in Series A from Lilly Ventures, Novartis Venture Fund and others.
Symic, a SF-based clinical-stage biotherapeutics company, secured $25m in Series A-2 financing led by Lilly Ventures.
Lilly Ventures and Novartis Venture Fund have led a $44m Series B funding round for Aeglea Biotherapeutics.
Read more news concerning Lilly Ventures
A sampling of Lilly Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?